Yuan-Jie Liu
Overview
Explore the profile of Yuan-Jie Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gu Y, Zhang J, Liu Y, Zhang Q, Geng Q
J Inflamm Res
. 2025 Mar;
18:3067-3091.
PMID: 40051449
Background: High transcription levels are essential for cancer cells to maintain their malignant phenotype. While RNA polymerases (POLRs) have been implicated in various transcriptional mechanisms, their impact on the tumor...
2.
Liu Y, Liu Q, Li J, Ye Q, Yin S, Liu C, et al.
Int Immunopharmacol
. 2025 Jan;
147():114065.
PMID: 39809103
Breslow thickness (BT), a parameter measuring the depth of invasion of abnormally proliferating melanocytes, is a key indicator of melanoma severity and prognosis. However, the mechanisms underlying the increase in...
3.
Kong Q, Gao Z, Liu Y, Jiang L, Liu Y, Lian Z
J Transl Med
. 2024 Oct;
22(1):890.
PMID: 39358724
Background: Numerous observational studies have indicated that patients with Guillain-Barré syndrome (GBS) frequently had infections with various pathogens before the onset of the disease, particularly several viral infections. Some of...
4.
Liu Y, Ye Q, Li J, Bai L, Zhang W, Wang S, et al.
Sci Rep
. 2024 Sep;
14(1):22596.
PMID: 39349535
As one of the two main histologic subtypes of gastric cancer (GC), diffuse-type gastric cancer (DGC) containing poorly cohesive gastric carcinoma (PCC) components has a worse prognosis and does not...
5.
Yin Q, Liu Y, Zhang Q, Xi S, Yang T, Li J, et al.
Int Immunopharmacol
. 2024 Sep;
142(Pt B):113184.
PMID: 39306894
Background: Mucinous carcinoma (MC) is a distinct histologic subtype of colorectal cancer (CRC) that is less studied and associated with poor prognosis. This study aimed to identify MC-specific therapeutic targets...
6.
Liu Y, Li J, Li J, Hu Y, Ma Z, Huang W, et al.
J Hepatocell Carcinoma
. 2024 Aug;
11:1519-1539.
PMID: 39139735
Background: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, underscoring the need for novel therapeutic targets. This study aimed to elucidate the role of endoplasmic reticulum membrane protein...
7.
Li J, Liu Y, Wang S, Lu Z, Ye Q, Zhou J, et al.
Int Immunopharmacol
. 2024 Jul;
139:112666.
PMID: 39002521
Immunotherapy has limited response rates in colorectal cancer (CRC) due to an immunosuppressive tumor microenvironment (TME). Combining transcriptome sequencing, clinical specimens, and functional experiments, we identified a unique group of...
8.
Liu Y, Li J, Han M, Li J, Ye Q, Lin S, et al.
J Transl Med
. 2024 Jun;
22(1):580.
PMID: 38898490
The importance of the immune microenvironment in poorly cohesive carcinoma (PCC) has been highlighted due to its limited response rate to conventional therapy and emerging treatment resistance. A combination of...
9.
Li J, Liu Y, Li Y, Yin Y, Ye Q, Lu Z, et al.
J Transl Med
. 2024 Jun;
22(1):549.
PMID: 38849852
Cellular communication (CC) influences tumor development by mediating intercellular junctions between cells. However, the role and underlying mechanisms of CC in malignant transformation remain unknown. Here, we investigated the spatiotemporal...
10.
Ye Q, Liu Y, Li J, Han M, Bian Z, Chen T, et al.
Transl Oncol
. 2024 Jun;
46:102009.
PMID: 38833783
Background: Colorectal cancer (CRC) is the third most common cancer worldwide. Connexin is a transmembrane protein involved in gap junctions (GJs) formation. Our previous study found that connexin 37 (Cx37),...